For the Inventor, By the Inventor

Enter assignee name

Teva Pharmaceutical Industries Limited

USPTO Granted Patents = 505

CIPO Patents = 20

EPO Patents = 80

Trademarks = 35

Forward Citations = 4,233

Loading Chart...

Loading Chart...

498 inventors (with patents filed for the assignee):

Judith Aronhime (68 out of 89 patents)

Ben-Zion Dolitzky (44 out of 51 patents)

Shlomit Wizel (32 out of 33 patents)

4. Marioara Mendelovici (30 out of 30 patents)

5. Tamar Nidam (28 out of 31 patents)

6. Claude Singer (28 out of 36 patents)

7. Nina Finkelstein (27 out of 27 patents)

8. Revital Lifshitz-Liron (27 out of 27 patents)

9. Valerie Niddam-Hildesheim (23 out of 27 patents)

10. Vinod Kumar Kansal (22 out of 25 patents)

11. Ruth Levy (21 out of 25 patents)

12. Anita Liberman (20 out of 20 patents)

13. Anton Frenkel (18 out of 21 patents)

14. Ramy Lidor-Hadas (18 out of 18 patents)

15. Haim Yellin (18 out of 20 patents)

Core Competencies:

Restless Legs Syndrome

Medical Injection Devices

S1P3 Antagonists

Reusable Injector Devices

Glatiramer Acetate

Predictive Biomarkers

Multiple Sclerosis

Laquinimod

Respiratory Apparatus

Albu-BChE Formulations

6-Mercaptopurine Formulations

Single Nucleotide Polymorphisms

505 patents: Sort by Forward Citations

1. 12310929 - Use of rasagiline for the treatment of restless legs syndrome (2025-05-27),

2. 11938298 - Medical injection device packaging (2024-03-26),

3. 11642451 - Medical injection device packaging (2023-05-09),

4. 11472772 - S1P3 antagonists (2022-10-18),

5. D936824 - Injector pen (2021-11-23),

6. 11135154 - Medroxyprogesterone acetate injectable compositions and methods of use (2021-10-05),

7. 10232124 - Re-useable injector device for syringe (2019-03-19),

8. 10130621 - Analogs of pridopidine, their preparation and use (2018-11-20),

9. 10071206 - Re-useable injector device for syringe (2018-09-11),

10. D827127 - Injector pen (2018-08-28),

11. 9951017 - S1P3 antagonists (2018-04-24),

12. 9827374 - Re-useable injector device for syringe (2017-11-28),

13. 9763993 - Process for manufacturing glatiramer acetate product (2017-09-19),

14. 9702007 - Genetic markers predictive of response to glatiramer acetate (2017-07-11),

15. 9687522 - Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis (2017-06-27),

Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, produces, and markets generic and branded medications. With a mission to improve health access worldwide, Teva specializes in specialty medicines used to treat various medical conditions, including respiratory, cardiovascular, and central nervous system disorders. They serve patients in over 60 countries and are committed to developing innovative solutions to address unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

505 Patents

#1 in

#11 in Israel

#1,870 in the World

Teva Pharmaceutical Industries Limited

Forward Citations = 4,233

498 inventors:

Judith Aronhime (68 out of 89 patents)

Ben-Zion Dolitzky (44 out of 51 patents)

Shlomit Wizel (32 out of 33 patents)

4. Marioara Mendelovici (30 out of 30 patents)

5. Tamar Nidam (28 out of 31 patents)

Please report any incorrect information to support@idiyas.com

Loading…